High number of PD‐1 positive intratumoural lymphocytes predicts survival benefit of cytokine‐induced killer cells for hepatocellular carcinoma patients

BACKGROUND & AIMS: Adjuvant cytokine‐induced killer (CIK) cells treatment has shown potential in reducing the recurrence rate and prolonging the survival of patients with hepatocellular carcinoma (HCC). We aimed to identify the best predictive biomarker for adjuvant CIK cells treatment in patien...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Liver Int
Main Authors: Chang, Boyang, Shen, Lujun, Wang, Kefeng, Jin, Jietian, Huang, Tao, Chen, Qifeng, Li, Wang, Wu, Peihong
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6099434/
https://ncbi.nlm.nih.gov/pubmed/29356308
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/liv.13697
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados